Time-course of oxidation of lipids in human cerebrospinal fluid in vitro

References

• Smith M.A., Sayre L.M., Monnier V.M., Perry G. Radical AGEing in Alzheimer's disease. Trends in Neurosciences 1995; 18: 172–176
   PubMed Web of Science ®Google Scholar
• Mark R.J., Blanc E.M., Mattson M.P. Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease. Molecular Neurobiology 1996; 12: 211–224
   PubMed Web of Science ®Google Scholar
• Przedborski S., Jackson-Lewis V. Experimental developments in movement disorders: update on proposed free radical mechanisms. Current Opinion in Neurology 1998; 11: 335–339
   Google Scholar
• Smith C.D., Carney J.M., Starke Reed P.E., Oliver C.N., Stadtman F.R., Floyd R.A., Markesbery W.R. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proceedings of the National Academy of Sciences of the USA 1991; 88: 10 540–10 543
   Google Scholar
• Takeda A., Yasuda T., Miyata T., Goto Y., Wakai M., Watanabe M., Yasuda Y., Horie K., Inagaki T., Doyu M., Maeda K., Sobue G. Advanced glycation end products co-localized with astrocytes and microglial cells in Alzheimer's disease brain. Acta Neuropathologica (Berlin) 1998; 95: 555–558
   Web of Science ®Google Scholar
• Dexter D.T., Carter C.J., Wells F.R., Javoy A.F., Agid Y., Lees A., Jenner P., Marsden C.D. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. Journal of Neurochemistry 1989; 52: 381–389
   PubMed Web of Science ®Google Scholar
• Alam Z.I., Daniel S.E., Lees A.J., Marsden D.C., Jenner P., Halliwell B. A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. Journal of Neurochemistry 1997; 69: 1326–1329
   PubMed Web of Science ®Google Scholar
• Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E.R., Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proceedings of the National Academy of Sciences of the USA 1996; 93: 2696–2701
   PubMed Web of Science ®Google Scholar
• Hensley K., Carney J.M., Mattson M.P., Aksenova M., Harris M., Wu J.F., Floyd R.A., Butterfield D.A. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proceedings of the National Academy of Sciences of the USA 1994; 91: 3270–3274
   PubMed Web of Science ®Google Scholar
• Forloni G. Neurotoxicity of beta-amyloid and prion peptides. Current Opinion in Neurology 1996; 9: 492–500
   Google Scholar
• Basun H., Forssell L.G., Wetterberg L., Winblad B. Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease. Journal of Neural Transmission Parkinson's Disease and Dementia Section 1991; 3: 231–258
   PubMedGoogle Scholar
• Dedman D.J., Treffry A., Candy J.M., Taylor G.A., Morris C.M., Bloxham C.A., Perry R.H., Edwardson J.A., Harrison P.M. Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients. Biochemical Journal 1992; 287: 509–514
   PubMed Web of Science ®Google Scholar
• Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Annals of Neurology 1995; 38: 357–366
   PubMed Web of Science ®Google Scholar
• Fitzgerald D.J. Zinc and Alzheimer's disease. Science 1995; 268: 1920–1920
   Google Scholar
• Selkoe D.J. Normal and abnormal biology of the beta-amyloid precursor protein. Annual Review of Neuroscience 1994; 17: 489–517
   PubMed Web of Science ®Google Scholar
• Seubert, P., Vigo, P.C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schlossmacher, M., Whaley, J., Swindlehurst, C., et al. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 1992; 359: 325–327
   PubMed Web of Science ®Google Scholar
• Loeffler D.A., DeMaggio A.J., Juneau P.L., Brickman C.M., Mashour G.A., Finkelman J.H., Pomara N., LeWitt P.A. Ceruloplasmin is increased in cerebrospinal fluid in Alzheimer's disease but not Parkinson's disease. Alzheimer Disease and Associated Disorders 1994; 8: 190–197
   Google Scholar
• Pitas R.E., Boyles J.K., Lee S.H., Hui D., Weisgraber K.H. Lipoproteins and their receptors in the central nervous system. Journal of Biological Chemistry 1987; 262: 14 352–14 360
   Google Scholar
• Borghini I., Barja F., Pometta D., James R.W. Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid. Biochimca et Biophysica Acta 1995; 1255: 192–200
   PubMed Web of Science ®Google Scholar
• Esterbauer H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radicals in Biology and Medicine 1992; 13: 341–390
   PubMed Web of Science ®Google Scholar
• Stocker R. Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance. Current Opinion in Lipidology 1994; 5: 422–433
   PubMedGoogle Scholar
• Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. Journal of Biological Chemistry 1997; 272: 20 963–20 966
   Google Scholar
• Buettner G.R. Use of ascorbate as test for catalytic metals in simple buffers. Methods in Enzymology 1990; 186: 125–127
   PubMed Web of Science ®Google Scholar
• Lonnrot K., Metsa Ketela T., Molnar G., Ahonen J.P., Latvala M., Peltola J., Pietila T., Alho H. The effect of ascorbate and ubiquinone supplementation on plasma and CSF total antioxidant capacity. Free Radicals in Biology and Medicine 1996; 21: 211–217
   PubMed Web of Science ®Google Scholar
• Kontush A., Hubner C., Finckh B., Kohlschütter A., Beisiegel U. How different constituents of low density lipoprotein determine its oxidizability by copper: a correlational approach. Free Radical Research 1996; 24: 135–147
   PubMed Web of Science ®Google Scholar
• Finckh B., Kontush A., Commentz J., Hubner C., Burdelski M., Kohlschütter A. Sensitive HPLC techniques for the simultaneous determination of tocopherols, tocotrienols, ubiquinols and ubiquinones in biological samples. Methods in Enzymology 1999; 299: 341–348
   PubMed Web of Science ®Google Scholar
• Barja G., Hernanz A. Vitamin C, dehydroascorbate, and uric acid in tissues and serum: high-performance liquid chromatography. Methods in Enzymology 1994; 234: 331–337
   PubMedGoogle Scholar
• Kontush A., Meyer S., Finckh B., Kohlschütter A., Beisiegel U. Alpha-tocopherol as a reductant for Cu(II) in human lipoproteins. Journal of Biological Chemistry 1996; 271: 11 106–11 112
   Google Scholar
• Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radical Research Communication 1989; 6: 67–75
   PubMed Web of Science ®Google Scholar
• Regnstrom J., Strom K., Moldeus P., Nilsson J. Analysis of lipoprotein diene formation in human serum exposed to copper. Free Radical Research Communication 1993; 19: 267–278
   PubMed Web of Science ®Google Scholar
• Schnitzer E., Pinchuk I., Fainaru M., Schafer Z., Lichtenberg D. Copper-induced lipid oxidation in unfractionated plasma: the lag preceding oxidation as a measure of oxidation-resistance. Biochemical and Biophysical Research Communication 1995; 216: 854–861
   PubMed Web of Science ®Google Scholar
• Kontush A., Beisiegel U. Measurement of oxidizability of blood plasma. Methods in Enzymology 1999; 299: 35–49
   PubMed Web of Science ®Google Scholar
• Kritharides L., Jessup W., Gifford J., Dean R.T. A method for defining the stages of low-density lipoprotein oxidation by the separation of cholesterol- and cholesteryl ester-oxidation products using HPLC. Annals of Biochemistry 1993; 213: 79–89
   Google Scholar
• Sattler W., Mohr D., Stocker R. Rapid isolation of lipoproteins and assessment of their peroxidation by high-performance liquid chromatography postcolumn chemiluminescence. Methods in Enzymology 1994; 233: 469–489
   PubMed Web of Science ®Google Scholar
• Fukunaga K., Suzuki T., Takama K. Highly sensitive high-performance liquid chromatography for the measurement of malondialdehyde in biological samples. Journal of Chromatography 1993; 621: 77–81
   Google Scholar
• Redgrave T.G., Roberts D.C., West C.E. Separation of plasma lipoproteins by density-gradient ultracentrifugation. Annals of Biochemistry 1975; 65: 42–49
   Google Scholar
• Illingworth D.R., Glover J. The composition of lipids in cerebrospinal fluid of children and adults. Journal of Neurochemistry 1971; 18: 769–776
   PubMedGoogle Scholar
• Vatassery G.T., Nelson M.J., Maletta G.J., Kuskowski M.A. Vitamin E (tocopherols) in human cerebrospinal fluid. American Journal of Clinical Nutrition 1991; 53: 95–99
   Google Scholar
• Lamb D.J., Leake D.S. Iron released from transferrin at acidic pH can catalyse the oxidation of low density lipoprotein. FEBS Letters 1994; 352: 15–18
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay C.K., Ehrenwald E., Fox P.L. Ceruloplasmin enhances smooth muscle cell- and endothelial cell-mediated low density lipoprotein oxidation by a superoxide-dependent mechanism. Journal of Biological Chemistry 1996; 271: 14 773–14 778
   Google Scholar
• Lamb D.J., Leake D.S. Acidic pH enables caeruloplasmin to catalyse the modification of low-density lipoprotein. FEBS Letters 1994; 338: 122–126
   PubMed Web of Science ®Google Scholar
• Frei B., England L., Ames B.N. Ascorbate is an outstanding antioxidant in human blood plasma. Proceedings of the National Academy of Sciences of the USA 1989; 86: 6377–6381
   PubMed Web of Science ®Google Scholar
• Bowry V.W., Stocker R. Tocopherol-mediated peroxidation. The prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. Journal of the American Chemical Society 1993; 115: 6029–6044
   Web of Science ®Google Scholar
• Karten B., Beisiegel U., Gercken G., Kontush A. Mechanisms of lipid peroxidation in human blood plasma: a kinetic approach. Chemistry and Physics of Lipids 1997; 88: 83–96
   PubMed Web of Science ®Google Scholar
• Ingold K.U., Bowry V.W., Stocker R., Walling C. Autoxidation of lipids and antioxidation by alpha-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein. Proceedings of the National Academy of Sciences of the USA 1993; 90: 45–49
   PubMed Web of Science ®Google Scholar
• Thomas S.R., Neuzil J., Mohr D., Stocker R. Coantioxidants make alpha-tocopherol an efficient anti-oxidant for low-density lipoprotein. American Journal of Clinical Nutrition 1995; 62: 1357S–1364S
   PubMed Web of Science ®Google Scholar
• Kontush A., Finckh B., Karten B., Kohlschutter A., Beisiegel U. Antioxidant and prooxidant activity of alpha-tocopherol in human plasma and low density lipoprotein. Journal of Lipid Research 1996; 37: 1436–1448
   PubMed Web of Science ®Google Scholar
• Spector R. Vitamin homeostasis in the central nervous system. New England Journal of Medicine 1977; 296: 1393–1398
   PubMed Web of Science ®Google Scholar
• Yamamoto S. Mammalian lipoxygenases: molecular structures and functions. Biochimca et Biophysica Acta 1992; 1128: 117–131
   PubMed Web of Science ®Google Scholar